Answer
Sep 10, 2024 - 02:41 PM
During an episode of migraine, a protein called calcitonin gene-related peptide receptor antagonists (CGRP) attaches to receptors, causing pain and inflammation. Qulipta was specifically designed to block the receptors that CGRP attaches to, reducing the severity and frequency of migraines.
